Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

From the energy factory to the intercellular communication medium: the emerging role of intercellular mitochondrial transfer and mitochondrial transplantation therapy in diabetes and diabetic complications

Li D., Liu X., Zhang L., Gong Q., Huang W., Xu Y.

Narrative Review on Type 2 Diabetes, published in J Transl Med (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Transl Med (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41742267
PMCID
PMC13041359
DOI
10.1186/s12967-026-07868-x

Abstract (original English)

BACKGROUND: Diabetes is a global chronic metabolic disorder that frequently results in multiple chronic complications. However, current therapeutic agents for diabetes and its complications fail to alleviate the core pathological process of mitochondrial dysfunction in affected target organs, rendering them incapable of fundamentally retarding the progression of these complications. MAINBODY: Mitochondrial transfer is a novel type of intercellular communication. Mitochondria can be transferred between cells and improve mitochondrial dysfunction in either the donor cell or the recipient cell. Accumulating evidence indicates that mitochondrial transfer exerts multiple regulatory effects to delay the progression of diabetes and its complications, including promoting insulin secretion, improving insulin resistance, facilitating the migration of vascular endothelial cells, and enhancing mitochondrial function in renal parenchymal cells. This review systematically summarizes the characteristics and molecular mechanisms of mitochondrial transfer, explores its pathophysiological implications in diabetes and related complications, and briefly discusses the application prospects of mitochondrial transplantation therapy in the management of diabetes and its complications based on the mitochondrial transfer theory. CONCLUSIONS: This review offers valuable insights and novel research direct

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
MitochondriaAnimalsHumansDiabetes MellitusDiabetes ComplicationsCell CommunicationEnergy Metabolism

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research